Abstract
Summary
Esketamine Nasal Spray is a medication used together with an antidepressant taken by mouth, for treating the patients of depression, who had taken atleast 2 antidepressants treatment that did not work. Esketamine nasal spray is also used as a general anaesthetics.
LPI (LP Information)' newest research report, the “Esketamine Nasal Spray Industry Forecast” looks at past sales and reviews total world Esketamine Nasal Spray sales in 2022, providing a comprehensive analysis by region and market sector of projected Esketamine Nasal Spray sales for 2023 through 2029. With Esketamine Nasal Spray sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Esketamine Nasal Spray industry.
This Insight Report provides a comprehensive analysis of the global Esketamine Nasal Spray landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Esketamine Nasal Spray portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Esketamine Nasal Spray market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Esketamine Nasal Spray and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Esketamine Nasal Spray.
The global Esketamine Nasal Spray market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Esketamine Nasal Spray is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Esketamine Nasal Spray is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Esketamine Nasal Spray is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Esketamine Nasal Spray players cover Pfizer Inc, Merck&Co, Medkoo, Endo International Plc and Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Esketamine Nasal Spray market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
General Anaesthetics
Treatment-Resistant Depression
Others
Segmentation by application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer Inc
Merck&Co
Medkoo
Endo International Plc
Johnson & Johnson
Key Questions Addressed in this Report
What is the 10-year outlook for the global Esketamine Nasal Spray market?
What factors are driving Esketamine Nasal Spray market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Esketamine Nasal Spray market opportunities vary by end market size?
How does Esketamine Nasal Spray break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Esketamine Nasal Spray Industry Forecast” looks at past sales and reviews total world Esketamine Nasal Spray sales in 2022, providing a comprehensive analysis by region and market sector of projected Esketamine Nasal Spray sales for 2023 through 2029. With Esketamine Nasal Spray sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Esketamine Nasal Spray industry.
This Insight Report provides a comprehensive analysis of the global Esketamine Nasal Spray landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Esketamine Nasal Spray portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Esketamine Nasal Spray market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Esketamine Nasal Spray and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Esketamine Nasal Spray.
The global Esketamine Nasal Spray market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Esketamine Nasal Spray is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Esketamine Nasal Spray is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Esketamine Nasal Spray is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Esketamine Nasal Spray players cover Pfizer Inc, Merck&Co, Medkoo, Endo International Plc and Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Esketamine Nasal Spray market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
General Anaesthetics
Treatment-Resistant Depression
Others
Segmentation by application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer Inc
Merck&Co
Medkoo
Endo International Plc
Johnson & Johnson
Key Questions Addressed in this Report
What is the 10-year outlook for the global Esketamine Nasal Spray market?
What factors are driving Esketamine Nasal Spray market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Esketamine Nasal Spray market opportunities vary by end market size?
How does Esketamine Nasal Spray break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Esketamine Nasal Spray Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Esketamine Nasal Spray by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Esketamine Nasal Spray by Country/Region, 2018, 2022 & 2029
2.2 Esketamine Nasal Spray Segment by Type
2.2.1 General Anaesthetics
2.2.2 Treatment-Resistant Depression
2.2.3 Others
2.3 Esketamine Nasal Spray Sales by Type
2.3.1 Global Esketamine Nasal Spray Sales Market Share by Type (2018-2023)
2.3.2 Global Esketamine Nasal Spray Revenue and Market Share by Type (2018-2023)
2.3.3 Global Esketamine Nasal Spray Sale Price by Type (2018-2023)
2.4 Esketamine Nasal Spray Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Esketamine Nasal Spray Sales by Application
2.5.1 Global Esketamine Nasal Spray Sale Market Share by Application (2018-2023)
2.5.2 Global Esketamine Nasal Spray Revenue and Market Share by Application (2018-2023)
2.5.3 Global Esketamine Nasal Spray Sale Price by Application (2018-2023)
3 Global Esketamine Nasal Spray by Company
3.1 Global Esketamine Nasal Spray Breakdown Data by Company
3.1.1 Global Esketamine Nasal Spray Annual Sales by Company (2018-2023)
3.1.2 Global Esketamine Nasal Spray Sales Market Share by Company (2018-2023)
3.2 Global Esketamine Nasal Spray Annual Revenue by Company (2018-2023)
3.2.1 Global Esketamine Nasal Spray Revenue by Company (2018-2023)
3.2.2 Global Esketamine Nasal Spray Revenue Market Share by Company (2018-2023)
3.3 Global Esketamine Nasal Spray Sale Price by Company
3.4 Key Manufacturers Esketamine Nasal Spray Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Esketamine Nasal Spray Product Location Distribution
3.4.2 Players Esketamine Nasal Spray Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Esketamine Nasal Spray by Geographic Region
4.1 World Historic Esketamine Nasal Spray Market Size by Geographic Region (2018-2023)
4.1.1 Global Esketamine Nasal Spray Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Esketamine Nasal Spray Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Esketamine Nasal Spray Market Size by Country/Region (2018-2023)
4.2.1 Global Esketamine Nasal Spray Annual Sales by Country/Region (2018-2023)
4.2.2 Global Esketamine Nasal Spray Annual Revenue by Country/Region (2018-2023)
4.3 Americas Esketamine Nasal Spray Sales Growth
4.4 APAC Esketamine Nasal Spray Sales Growth
4.5 Europe Esketamine Nasal Spray Sales Growth
4.6 Middle East & Africa Esketamine Nasal Spray Sales Growth
5 Americas
5.1 Americas Esketamine Nasal Spray Sales by Country
5.1.1 Americas Esketamine Nasal Spray Sales by Country (2018-2023)
5.1.2 Americas Esketamine Nasal Spray Revenue by Country (2018-2023)
5.2 Americas Esketamine Nasal Spray Sales by Type
5.3 Americas Esketamine Nasal Spray Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Esketamine Nasal Spray Sales by Region
6.1.1 APAC Esketamine Nasal Spray Sales by Region (2018-2023)
6.1.2 APAC Esketamine Nasal Spray Revenue by Region (2018-2023)
6.2 APAC Esketamine Nasal Spray Sales by Type
6.3 APAC Esketamine Nasal Spray Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Esketamine Nasal Spray by Country
7.1.1 Europe Esketamine Nasal Spray Sales by Country (2018-2023)
7.1.2 Europe Esketamine Nasal Spray Revenue by Country (2018-2023)
7.2 Europe Esketamine Nasal Spray Sales by Type
7.3 Europe Esketamine Nasal Spray Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Esketamine Nasal Spray by Country
8.1.1 Middle East & Africa Esketamine Nasal Spray Sales by Country (2018-2023)
8.1.2 Middle East & Africa Esketamine Nasal Spray Revenue by Country (2018-2023)
8.2 Middle East & Africa Esketamine Nasal Spray Sales by Type
8.3 Middle East & Africa Esketamine Nasal Spray Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Esketamine Nasal Spray
10.3 Manufacturing Process Analysis of Esketamine Nasal Spray
10.4 Industry Chain Structure of Esketamine Nasal Spray
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Esketamine Nasal Spray Distributors
11.3 Esketamine Nasal Spray Customer
12 World Forecast Review for Esketamine Nasal Spray by Geographic Region
12.1 Global Esketamine Nasal Spray Market Size Forecast by Region
12.1.1 Global Esketamine Nasal Spray Forecast by Region (2024-2029)
12.1.2 Global Esketamine Nasal Spray Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Esketamine Nasal Spray Forecast by Type
12.7 Global Esketamine Nasal Spray Forecast by Application
13 Key Players Analysis
13.1 Pfizer Inc
13.1.1 Pfizer Inc Company Information
13.1.2 Pfizer Inc Esketamine Nasal Spray Product Portfolios and Specifications
13.1.3 Pfizer Inc Esketamine Nasal Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Inc Main Business Overview
13.1.5 Pfizer Inc Latest Developments
13.2 Merck&Co
13.2.1 Merck&Co Company Information
13.2.2 Merck&Co Esketamine Nasal Spray Product Portfolios and Specifications
13.2.3 Merck&Co Esketamine Nasal Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck&Co Main Business Overview
13.2.5 Merck&Co Latest Developments
13.3 Medkoo
13.3.1 Medkoo Company Information
13.3.2 Medkoo Esketamine Nasal Spray Product Portfolios and Specifications
13.3.3 Medkoo Esketamine Nasal Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Medkoo Main Business Overview
13.3.5 Medkoo Latest Developments
13.4 Endo International Plc
13.4.1 Endo International Plc Company Information
13.4.2 Endo International Plc Esketamine Nasal Spray Product Portfolios and Specifications
13.4.3 Endo International Plc Esketamine Nasal Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Endo International Plc Main Business Overview
13.4.5 Endo International Plc Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Esketamine Nasal Spray Product Portfolios and Specifications
13.5.3 Johnson & Johnson Esketamine Nasal Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
14 Research Findings and Conclusion